4.2. Analysis.
Comparison 4 DA‐9701 30 mg three times a day versus itopride 50 mg three times a day, Outcome 2 Post‐treatment scores.
Comparison 4 DA‐9701 30 mg three times a day versus itopride 50 mg three times a day, Outcome 2 Post‐treatment scores.